The Institutional Case for Robotic Surgery in Women's Health
- August / September 2026 TBD
Robotic surgery in gynaecology has a well-documented clinical story. The investment story is less well told. This session brings together capital allocators, health system decision-makers, and institutional investors to examine where funding is moving, what health systems are committing to, and why surgical robotics in women’s health is a structurally underleveraged thesis.
Improving Healthcare for Women and Generating Real Investor ROI
- Thu, 27 May 2026 18:00 - 19:00 CEST
Join us online as we explore how improving healthcare for women is emerging as a compelling investment opportunity where the right technology, the right teams, and the right timing are converging to generate real, scalable returns.
Women’s Hormonal Health: Why Investors Are Paying Attention
- Thu, 19 Feb 2026 19:00 - 20:00 CET
Join us online as we discuss how women’s hormonal health is emerging as a structurally investable segment of healthcare and the business models shaping this phase.
The Business of Women’s Health 2026: Key Trends and Insights
- Thu, 23 Oct 2025 18:00 - 19:00 CEST
Powered by Events Manager